Summary

In-vitro Colorectal Cancer Screening Tests Market – Scope of Report
TMR’s report on the global in-vitro colorectal cancer screening tests market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global in-vitro colorectal cancer screening tests market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro colorectal cancer screening tests market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in-vitro colorectal cancer screening tests market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro colorectal cancer screening tests market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in-vitro colorectal cancer screening tests market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro colorectal cancer screening tests market.

The report delves into the competitive landscape of the global in-vitro colorectal cancer screening tests market. Key players operating in the global in-vitro colorectal cancer screening tests market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in-vitro colorectal cancer screening tests market profiled in this report.

Key Questions Answered in Global in-vitro colorectal cancer screening tests Market Report
• What is the sales/revenue generated by in-vitro colorectal cancer screening tests across all regions during the forecast period?
• What are the opportunities in the global in-vitro colorectal cancer screening tests market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

In-vitro Colorectal Cancer Screening Tests Market – Research Objectives and Research Approach
The comprehensive report on the global in-vitro colorectal cancer screening tests market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro colorectal cancer screening tests market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in-vitro colorectal cancer screening tests market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In-vitro Colorectal Cancer Screening Tests Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, 2020-2034
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Porter’s Five Force Analysis
    5.2. Key Industry Events
    5.3. Prevalence of Cancer
6. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By Test Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Test Type, 2020-2034
        6.3.1. Fecal DNA Test Kits
        6.3.2. Fecal immunochemical Test (FIT)
        6.3.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
        6.3.4. Others
    6.4. Market Attractiveness By Test Type
7. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By End-user
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By End-user, 2020-2034
        7.3.1. Hospitals & Clinics
        7.3.2. Diagnostic Centers
        7.3.3. Others
    7.4. Market Attractiveness By End-user
8. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By Region
    8.1. Key Findings
    8.2. Market Value Forecast By Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness By Country/Region
9. North America In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast By Test Type, 2020-2034
        9.2.1. Fecal DNA Test Kits
        9.2.2. Fecal immunochemical Test (FIT)
        9.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
        9.2.4. Others
    9.3. Market Value Forecast By End-user, 2020-2034
        9.3.1. Hospitals & Clinics
        9.3.2. Diagnostic Centers
        9.3.3. Others
    9.4. Market Value Forecast By Country, 2020-2034
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Test Type
        9.5.2. By End-user
        9.5.3. By Country
10. Europe In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast By Test Type, 2020-2034
        10.2.1. Fecal DNA Test Kits
        10.2.2. Fecal immunochemical Test (FIT)
        10.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
        10.2.4. Others
    10.3. Market Value Forecast By End-user, 2020-2034
        10.3.1. Hospitals & Clinics
        10.3.2. Diagnostic Centers
        10.3.3. Others
    10.4. Market Value Forecast By Country, 2020-2034
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Italy
        10.4.5. Spain
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Test Type
        10.5.2. By End-user
        10.5.3. By Country
11. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Test Type, 2020-2034
        11.2.1. Fecal DNA Test Kits
        11.2.2. Fecal immunochemical Test (FIT)
        11.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
        11.2.4. Others
    11.3. Market Value Forecast By End-user, 2020-2034
        11.3.1. Hospitals & Clinics
        11.3.2. Diagnostic Centers
        11.3.3. Others
    11.4. Market Value Forecast By Country, 2020-2034
        11.4.1. China
        11.4.2. India
        11.4.3. Japan
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Test Type
        11.5.2. By End-user
        11.5.3. By Country
12. Latin America In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Test Type, 2020-2034
        12.2.1. Fecal DNA Test Kits
        12.2.2. Fecal immunochemical Test (FIT)
        12.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
        12.2.4. Others
    12.3. Market Value Forecast By End-user, 2020-2034
        12.3.1. Hospitals & Clinics
        12.3.2. Diagnostic Centers
        12.3.3. Others
    12.4. Market Value Forecast By Country, 2020-2034
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Test Type
        12.5.2. By End-user
        12.5.3. By Country
13. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Test Type, 2020-2034
        13.2.1. Fecal DNA Test Kits
        13.2.2. Fecal immunochemical Test (FIT)
        13.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
        13.2.4. Others
    13.3. Market Value Forecast By End-user, 2020-2034
        13.3.1. Hospitals & Clinics
        13.3.2. Diagnostic Centers
        13.3.3. Others
    13.4. Market Value Forecast By Country, 2020-2034
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Test Type
        13.5.2. By End-user
        13.5.3. By Country
14. Competition Landscape
    14.1. Market Player - Competition Matrix (By Tier and Size of companies)
    14.2. Market Share Analysis By Company (2023)
    14.3. Company Profiles
        14.3.1. Abbott Laboratories
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Product Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. Thermofisher Scientific Inc.
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Product Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. Eiken Chemical Co., Ltd
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Product Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. Qiagen
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Product Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. Quest Diagnostics Incorporated
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Product Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
            14.3.5.5. Strategic Overview
        14.3.6. Sentinel CH. SpA
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Product Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
            14.3.6.5. Strategic Overview
        14.3.7. Quidel Corporation
            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.7.2. Product Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. SWOT Analysis
            14.3.7.5. Strategic Overview
        14.3.8. Freenome Holdings, Inc.
            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.8.2. Product Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. SWOT Analysis
        14.3.9. Immunostics, Inc.
            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.9.2. Product Portfolio
            14.3.9.3. Financial Overview
            14.3.9.4. SWOT Analysis
        14.3.10. BTNX, Inc.
            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.10.2. Product Portfolio
            14.3.10.3. Financial Overview
            14.3.10.4. SWOT Analysis